McElhenny Sheffield Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Sell	924 -34	-4%	-$16.3K	0.11%	39
2026 Q1	$471K	Buy	958 +45	+5%	+$24.4K	0.12%	39
2025 Q4	$529K	Buy	913 +1	+0.1%	+$566	0.13%	35
2025 Q3	$442K	Buy	912 +106	+13%	+$49.3K	0.1%	56
2025 Q2	$327K	Hold	806	–	–	0.09%	81
2025 Q1	$401K	Buy	806 +5	+0.6%	+$2.71K	0.15%	72
2024 Q4	$417K	Buy	801 +1	+0.1%	+$550	0.14%	65
2024 Q3	$495K	Hold	800	–	–	0.16%	58
2024 Q2	$442K	Hold	800	–	–	0.15%	61
2024 Q1	$465K	Hold	800	–	–	0.17%	57
2023 Q4	$425K	Hold	800	–	–	0.17%	57
2023 Q3	$405K	Hold	800	–	–	0.21%	55
2023 Q2	$417K	Sell	800 -4	-0.5%	-$2.16K	0.18%	57
2023 Q1	$463K	Sell	804 -1	-0.1%	-$564	0.24%	59
2022 Q4	$443K	Buy	805 +5	+0.6%	+$2.65K	0.21%	57
2022 Q3	$406K	Hold	800	–	–	0.31%	50
2022 Q2	$435K	Hold	800	–	–	0.2%	60
2022 Q1	$473K	Hold	800	–	–	0.17%	70
2021 Q4	$534K	Hold	800	–	–	0.2%	69
2021 Q3	$457K	Buy	+800	New	+$439K	0.21%	76

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

McElhenny Sheffield Capital Management's TMO Position: Q2 2026 in Review

McElhenny Sheffield Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $16.3K and leaving 924 shares worth $463K. The position accounts for 0.11% of the portfolio, ranked #39.

McElhenny Sheffield Capital Management first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $534K in Q4 2021. 797 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

McElhenny Sheffield Capital Management held 924 shares of Thermo Fisher Scientific worth $463K as of Q2 2026.
McElhenny Sheffield Capital Management sold 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
Thermo Fisher Scientific made up 0.11% of McElhenny Sheffield Capital Management's portfolio in Q2 2026, its #39 holding.
McElhenny Sheffield Capital Management first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
McElhenny Sheffield Capital Management's Thermo Fisher Scientific position peaked at $534K in Q4 2021.
797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.